AK

Atul Kumar Shukla

Active Director Director DIN 10402955
DIN 10402955 First appointment Nov 2023 Primary industry Paper
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2023
Shareholding value •••• Premium profile

About Atul Kumar Shukla

Data last updated:

Atul Kumar Shukla is a Director at Rantomo Life Sciences Bharat Private Limited (since 2023). The company operates in Paper. Rantomo Life Sciences Bharat Private Limited reported revenue of ₹2.96 Cr (FY 2025).

DIN 10402955
Primary Designation Director
Industry Paper
First Appointment 23 Nov 2023
Oldest Company Age 2 yrs
Largest company Rantomo Life Sciences Bharat Private Limited · ₹2.96 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director23 Nov 20232023₹2.96 Cr (FY 2025)Active

Board colleagues of Atul Kumar Shukla

Directorship timeline

Open interactive timeline →
Rantomo Life Sciences Bharat Private Limited
Premium access

Shareholding and investment profile for Atul Kumar Shukla

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Atul Kumar Shukla

Atul Kumar Shukla currently holds 1 directorship: Rantomo Life Sciences Bharat Private Limited (Director, since 23 Nov 2023, revenue ₹2.96 Cr (FY 2025)).

Atul Kumar Shukla was first appointed on 23 Nov 2023 as Director at Rantomo Life Sciences Bharat Private Limited.

The current boards of Atul Kumar Shukla's companies include Nitin Sheshnarayan Tiwari (Rantomo Life Sciences Bharat Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available